STABILITY INDICATING HPTLC METHOD DEVELOPMENT AND VALIDATION FOR COMBINED DOSAGE FORM OF TOLPERISONE HYDROCHLORIDE AND DICLOFENAC SODIUM
Abstract
A simple HPTLC method has been developed and subsequently validated for tablet
dosage form. The method employed TLC aluminum plates precoated with silica gel
60F254 as the stationary phase. The solvent system consist of Methanol: Toluene:
Ethyl Acetate (2.5:7:0.5 v/v/v) and saturation time was 25 min.This system was found
to give compact spots for diclofenac sodium (Rf =0.7±) and tolperisone hydrochloride
(Rf 0.5).Analysis of tolperisone hydrochloride, diclofenac sodium was carried out at
275nm. Linearity of diclofenac sodium and tolperisone hydrochloride was found to be
y = 5.3727x + 4514.2, R2=0.998, y = 9.376x + 2635.6, R2=0.995 respectively in
concentration range of 300-1500 µg/bandand 100-300 µg/band. %Assay of
tolperisone hydrochloride and diclofenac sodium was found to be 99.16%w/v and
99.60 %w/v.Results of all other experiments for method validation were found within
the specified criteria of ICH guideline.
Downloads
Author(s) and co-author(s) jointly and severally represent and warrant that the Article is original with the author(s) and does not infringe any copyright or violate any other right of any third parties, and that the Article has not been published elsewhere. Author(s) agree to the terms that the IJRDO Journal will have the full right to remove the published article on any misconduct found in the published article.